1. Antihistamines may reduce cotrimoxazole-induced rash in AIDS

   Newsletter Article 29 January 2013 Pages: 1 - 1

2. Discuss the adverse effects of tamoxifen with patients

   Newsletter Article 29 January 2013 Pages: 1 - 1

3. WHO measles vaccine recommendations questioned

   Newsletter Article 29 January 2013 Pages: 1 - 1

4. Who should receive misoprostol prophylaxis against NSAID-induced ulceration?

   Newsletter Article 29 January 2013 Pages: 2 - 3

5. ‘Prozac’ - is the fall from angel to demon justified? …

   Newsletter Article 29 January 2013 Pages: 3 - 3

6. … the FDA thinks not…

   Newsletter Article 29 January 2013 Pages: 3 - 3

7. … and the risks are weighed

   Newsletter Article 29 January 2013 Pages: 3 - 4

8. ACE inhibitor overdose

   Newsletter Article 29 January 2013 Pages: 4 - 4

9. Acetylcysteine

   Newsletter Article 29 January 2013 Pages: 4 - 4

10. Amantadine

    Newsletter Article 29 January 2013 Pages: 4 - 4

11. Aminophylline see Pancuronium bromide interaction

    Newsletter Article 29 January 2013 Pages: 4 - 4

12. Amitriptyline/phenelzine

    Newsletter Article 29 January 2013 Pages: 4 - 4

13. Antineoplastics

    Newsletter Article 29 January 2013 Pages: 4 - 4

14. Antipsychotics

    Newsletter Article 29 January 2013 Pages: 4 - 5

15. Arsenic

    Newsletter Article 29 January 2013 Pages: 5 - 5

16. Atropine

    Newsletter Article 29 January 2013 Pages: 5 - 5

17. Barbiturates

    Newsletter Article 29 January 2013 Pages: 5 - 5

18. Busulfan/cyclophosphamide

    Newsletter Article 29 January 2013 Pages: 5 - 5

19. Carbamazepine overdose

    Newsletter Article 29 January 2013 Pages: 5 - 5

20. Cefazolin

    Newsletter Article 29 January 2013 Pages: 5 - 5

21. Chloroquine see Clozapine interaction

    Newsletter Article 29 January 2013 Pages: 5 - 5

22. Ciprofloxacin see Theophylline interaction

    Newsletter Article 29 January 2013 Pages: 5 - 5

23. Clonidine/prazosin

    Newsletter Article 29 January 2013 Pages: 5 - 6

24. Clozapine interaction

    Newsletter Article 29 January 2013 Pages: 6 - 6

25. Cocaine abuse

    Newsletter Article 29 January 2013 Pages: 6 - 6

26. Corticosteroids

    Newsletter Article 29 January 2013 Pages: 6 - 6

27. Cyclophosphamide see Busulfan/cyclophosphamide

    Newsletter Article 29 January 2013 Pages: 6 - 6

28. Cyclosporin

    Newsletter Article 29 January 2013 Pages: 6 - 6

29. Digitalis overdose

    Newsletter Article 29 January 2013 Pages: 6 - 6

30. Ergotamine

    Newsletter Article 29 January 2013 Pages: 6 - 7

31. Estrogen/progesterone

    Newsletter Article 29 January 2013 Pages: 7 - 7

32. Eugenol

    Newsletter Article 29 January 2013 Pages: 7 - 7

33. Factor IX

    Newsletter Article 29 January 2013 Pages: 7 - 7

34. Felodipine

    Newsletter Article 29 January 2013 Pages: 7 - 7

35. Fentanyl see Midazolam/fentanyl withdrawal

    Newsletter Article 29 January 2013 Pages: 7 - 7

36. Fluorouracil

    Newsletter Article 29 January 2013 Pages: 7 - 7

37. Fluoxetine overdose

    Newsletter Article 29 January 2013 Pages: 7 - 7

38. Gemfibrozil/lovastatin

    Newsletter Article 29 January 2013 Pages: 7 - 8

39. Glafenine

    Newsletter Article 29 January 2013 Pages: 8 - 8

40. Glipizide

    Newsletter Article 29 January 2013 Pages: 8 - 8

41. Haloperidol

    Newsletter Article 29 January 2013 Pages: 8 - 8

42. Ibuprofen overdose

    Newsletter Article 29 January 2013 Pages: 8 - 8

43. Immunotherapy

    Newsletter Article 29 January 2013 Pages: 8 - 8

44. Infertility therapies

    Newsletter Article 29 January 2013 Pages: 8 - 8

45. Interferon alpha 2

    Newsletter Article 29 January 2013 Pages: 8 - 9

46. Interferon alpha see Interleukin 2/interferon alpha/lymphokine activated killer cells

    Newsletter Article 29 January 2013 Pages: 9 - 9

47. Interleukin 2

    Newsletter Article 29 January 2013 Pages: 9 - 9

48. Interleukin 2/interferon alpha/lymphokine activated killer cells

    Newsletter Article 29 January 2013 Pages: 9 - 9

49. Iohexol

    Newsletter Article 29 January 2013 Pages: 9 - 9

50. Ketorolac

    Newsletter Article 29 January 2013 Pages: 9 - 9